Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy

Paola Faverio,1,2 Giulia Bonaiti,1,2 Francesco Bini,3 Adriano Vaghi,3 Alberto Pesci1,2 1School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; 2Respiratory Unit, San Gerardo Hospital, ASST di Monza, Monza, Italy; 3ASST-Rhodense, UOC Pneumologia, Garbagnate Milanese, Milan, Ital...

Full description

Bibliographic Details
Main Authors: Faverio P, Bonaiti G, Bini F, Vaghi A, Pesci A
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Therapeutics and Clinical Risk Management
Subjects:
mepolizumab
eosinophilic granulomatosis with polyangiitis
Churg Strauss Syndrome
Online Access:https://www.dovepress.com/mepolizumab-as-the-first-targeted-treatment-for-eosinophilic-granuloma-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/mepolizumab-as-the-first-targeted-treatment-for-eosinophilic-granuloma-peer-reviewed-article-TCRM

Similar Items